Category Archive: Healthcare

Bayer-Monsanto: A Genetically Modified Deal

by

On September 14th, 2016, Bayer has reached a deal, currently pending regulatory approval, to acquire Monsanto in an all cash transaction for $128-a-share ($56bn Equity Value, $66bn EV) COMPANY OVERVIEW – BAYER Bayer… Continue reading

ChemChina still in the run for its global primacy, this time is the agrochemical giant Syngenta to fall in its arms

by

On February 3rd, 2016 ChemChina announced its acquisition of Syngenta’s 100% outstanding share capital at $465 per ordinary share and a special dividend of CHF 5 to be paid only conditionally on the… Continue reading

Abbott’s acquisition of Alere: reshaping the market for rapid medical tests

by

Abbott Laboratories (NYSE:ABT) announced on February 1st, 2016 the acquisition of Alere (NYSE:ALR). The deal comes just few days after Abbott reported a drop of 15% in its profits for the final quarter… Continue reading

Pfizer – Allergan

by

A new Pharma Mega-Deal making Botox and Viagra join forces. On November 23, 2015, Pfizer announced its $160bn tie-up with Allergan to form the world’s biggest pharmaceutical company by sales. Industry Overview Even… Continue reading

Pfizer’s acquisition of Hospira, the M&A wave in the healthcare sector still far from settling down

by

In February 2015, Pfizer announced that it wants to acquire its smaller rival Hospira to make Pfizer the leading producer in the biosimilars sector, a high-growth niche sector focusing on lower cost biotech… Continue reading

A NEW OUTBURST OF THE HEALTHCARE M&A FIRE – TEVA TO ACQUIRE ALLERGAN

by

Teva Pharmaceutical Industries will pay $40.5bn in cash and stock for Allergan’s generic drug business, sustaining Teva’s position as the world’s number one producer of generics. Industry Overview Teva Pharmaceutical Industries Ltd. is… Continue reading

A “LOWBALL OPENING” – SHIRE’S TAKEOVER OFFER FOR BAXALTA

by

Shire made a $30bn (£19bn) hostile takeover bid for Baxalta. Industry overview Shire is a London-listed drug company, with tax domicile in Ireland and Jersey. Shire develops and provides healthcare in the areas of behavioral… Continue reading

GENERICALLY SPEAKING, HEALTHCARE M&A IS ON FIRE

by

Industry Overview During the past weeks we observed a lot of activity in the healthcare sector centering around three companies: Mylan, Perrigo and Teva. Mylan is a Dutch pharmaceutical company headquartered in Amsterdam.… Continue reading

THE END OF A TRILOGY – VALEANT ON SALIX CASE.

by

The increased M&A activity within the Healthcare sector has not slowed down in 2015, after we saw a record volume of transactions in the previous year. After securing financing, Canada-based Valeant has won… Continue reading